Publications (9) Cristina Azpitarte Raposeiras publications

filter_list

2025

  1. Assessment of efficacy, safety, and prognostic/predictive factors of nintedanib/docetaxel in advanced/recurrent non–small cell lung cancer post-immunotherapy and chemotherapy: A Galician Lung Cancer Group study

    Cancer Treatment and Research Communications, Vol. 44

  2. Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish ‘Cambados annual meeting’

    Clinical and Translational Oncology

  3. Correction: Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish ‘Cambados annual meeting’ (Clinical and Translational Oncology, (2025), 27, 8, (3307-3324), 10.1007/s12094-025-03850-z)

    Clinical and Translational Oncology

  4. Guía clínica para la sedación al final de la vida. PRO-ASPS-PSQ-01-27

  5. Real-world clinical experience with osimertinib in advanced EGFR-mutated non-small cell lung cancer

    Clinical and Translational Oncology

2021

  1. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

    Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415

2019

  1. Evaluation of the lung immune prognostic index in advanced nonsmall cell lung cancer patients under nivolumab monotherapy

    Translational Lung Cancer Research, Vol. 8, Núm. 6, pp. 1078-1085

2018

  1. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

    Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1467-1473

2016

  1. Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)

    Oncology Letters, Vol. 12, Núm. 2, pp. 1403-1407